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Received October 12, 2015; accepted April 13, 2016AbstractEndometriosis, defined by the presence of viable extrauterine endometrial glands and stroma, can grow or bleed cyclically, and possesses
characteristics including a destructive, invasive, and metastatic nature. Since endometriosis may result in pelvic inflammation, adhesion, chronic
pain, and infertility, and can progress to biologically malignant tumors, it is a long-term major health issue in women of reproductive age. In this
review, we analyze the Taiwan domestic research addressing associations between endometriosis and other diseases. Concerning malignant
tumors, we identified four studies on the links between endometriosis and ovarian cancer, one on breast cancer, two on endometrial cancer, one
on colorectal cancer, and one on other malignancies, as well as one on associations between endometriosis and irritable bowel syndrome, one on
links with migraine headache, three on links with pelvic inflammatory diseases, four on links with infertility, four on links with obesity, four on
links with chronic liver disease, four on links with rheumatoid arthritis, four on links with chronic renal disease, five on links with diabetes
mellitus, and five on links with cardiovascular diseases (hypertension, hyperlipidemia, etc.). The data available to date support that women with
endometriosis might be at risk of some chronic illnesses and certain malignancies, although we consider the evidence for some comorbidities to
be of low quality, for example, the association between colon cancer and adenomyosis/endometriosis. We still believe that the risk of co-
morbidity might be higher in women with endometriosis than that we supposed before. More research is needed to determine whether women
with endometriosis are really at risk of these comorbidities.
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Endometriosis, one of the most common gynecologic dis-
orders, is found in 1e30% of women during their reproductive
years, based on the different diagnostic criteria, and sometimes
occurs in postmenopausal women. It is found in 70e90% of
women with pelvic pain symptoms.1e3 Endometriosis remains
an enigmatic disease and cause of pain, and can subsequently
result in pelvic inflammation, adhesion, chronic pain, andsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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Since endometriosis-associated morbidity shows a significant
negative impact on women's quality of life, it contributes to a
long-term major health issue. This study report addresses the
associations between endometriosis and other diseases from
the domestic source in Taiwan. The majority of the data are
obtained from a large-scale population-based studydthe Na-
tional Health Insurance Research Database (NHIRD).6,7
2. Epidemiology
Epidemiologic studies may be helpful in defining pop-
ulations at a high risk of endometriosis1,3e5; however, it is not
easy to estimate the real incidence or prevalence of endo-
metriosis precisely even when the gold-standard method,
laparoscopy, is used. Variations may be influenced by the
wide range of visual appearance of endometriosis and path-
ological confirmation, resulting in an unknown true preva-
lence or the real incidence of endometriosis. Hopton and
Redwine8 noted that the visual appearance of endometriosis is
important because therapy begins with a surgeon identifying
the disease, and any inaccurate identification of endometriosis
can introduce selection bias and confound all conclusions,
leading to incorrect concepts of epidemiology, natural history,
disease origin, and treatment. In 1995, Chu and colleagues'9
pioneered study of the prevalence of endometriosis in
Taiwan showed a wide variation (5e42%) on the basis of
different indications for 752 consecutive laparoscopic pro-
cedures. The prevalence of endometriosis was 42%, 33%,
25%, and 12%, respectively, in women indicated for pelvic
adhesion, infertility, myoma, and sterilization; the researchers
concluded that the overall prevalence of endometriosis in
asymptomatic patients was 24.7%. This study was one of the
earliest to investigate the prevalence of endometriosis in
Taiwan. However, this study might overestimate or underes-
timate the prevalence of endometriosis in Taiwan. Since sur-
gery is always applied in a certain type of population, for
example, women with needs and indications, surgery itself
might be one of the most significant confounding factors,
contributing to the high possibility of selection bias. In
addition, the “illusory tale of occult microscopic endometri-
osis” might underestimate the prevalence of endometriosis.8
Endometriosis is sometimes truly invisible to the surgeon
because it is too small to see.8 In previous studies from
Taiwan,1,3e5 the prevalence of endometriosis also varied
markedly. With different criteria applied for enrollment of
patients with endometriosis, the prevalence might be different.
A recent report by Lee et al3 might be one of the best rep-
resentatives. Their results showed that the prevalence of
endometriosis during reproductive years could be up to 30.8%
and as low as 1.5%.3 The dramatic difference in the preva-
lence could be well explained by the different criteria applied
in the study. Yang et al1 showed that the estimated prevalence
of women with endometriosis was 8.9% based on the NHIRD
of Taiwan. However, only two-fifths of these women with a
clinical diagnosis of endometriosis had a surgicopathological
confirmation of their endometriosis, contributing to 3.7% ofthe prevalence rate,3 which was significantly lower than the
5e10% rate found in literature reviews.10
3. Comorbidity of endometriosis
Previous research suggests that a comorbidity relationship
exists between endometriosis and many functional and/or
pathological diseases,1,11,12 although the results of some studies
were not consistent. For example, endometriosis was not
associated with diabetes mellitus in one cross-sectional study,13
and reports showed that women with endometriosis might have
a lower body mass index and be less frequently obese14,15;
however, domestic nationwide population-based studies
showed that women with endometriosis seemed to have a
tendency of being obese and a higher rate of diabetes melli-
tus.4,5,11,12 One report showed 7.5% of women with diabetes
mellitus in the endometriosis group compared with 5.8% in the
nonendometriosis (control) group.4 Another report found dia-
betes mellitus in 16% of women with endometriosis compared
with that in 13% of women without endometriosis.12 Besides a
higher rate of diabetes mellitus in women with endometriosis,
domestic data showed that Taiwanese women with endome-
triosis seemed to have a higher tendency to be obese.11,12 This
finding was different from those of previous reports from
Western countries14,15da discrepancy that needs further
investigation. Of course, different criteria might have resulted
in the different prevalence estimations, suggesting that sam-
pling differences might have contributed to this finding.
A domestic study also found that a higher proportion of
women with endometriosis had pelvic inflammatory disease
(76.0% vs. 38.4%, endometriosis vs. controls, p < 0.0001),
infertility (10.2% vs. 2.0%, p < 0.0001), cardiovascular dis-
eases (4.9% vs. 3.5%, p < 0.0001), chronic liver disease (2.2%
vs. 1.5%, p ¼ 0.0002), and rheumatic disease (4.0% vs. 2.4%,
p < 0.0001).4 Similar findings were also reported from another
domestic population-based study.12 Wu et al12 showed that
women with endometriosis frequently had hypertension
(24.0% vs. 20.6%, p < 0.001) and hyperlipidemia (28.7% vs.
23.0%, p < 0.001). Both hypertension and hyperlipidemia
might be considered among the important components of
cardiovascular diseases, suggesting that women with endo-
metriosis are frequently associated with metabolic and car-
diovascular problems. By contrast, a recent domestic study
showed that women with endometriosis had a lower rate of
hypertension than women without endometriosis. Although
this study did not support a higher incidence of hypertension
in women with endometriosis, the finding could be discarded,
mainly because Yu et al's11 study showed an unusually higher
proportion of hypertension in their study population. More
than one-half of their studied patients had hypertension status;
this occurred in both cohort groups (50.7% of women with
endometriosis and 55.7% of women without endometriosis,
p < 0.001), suggesting that the study population might not
really be representative of the general population. In addition,
Yu et al11 also showed an unusually higher proportion of study
population with hyperlipidemia (53.9% and 44.9% in women
with and without endometriosis, respectively; p < 0.001) and
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without endometriosis, respectively; p < 0.001) than that of
the general population.
In addition to the higher comorbidity, women with endo-
metriosis might also have a higher risk of other medical ill-
nesses. For example, Wu et al12 showed that women with
endometriosis had a higher rate of depression (1.0% vs. 0.5%,
p < 0.001) than those without it. Taken together, women with
endometriosis should be given much attention for medical
care, since they not only have endometriosis-related health
problems, such as dysmenorrhea, menorrhagia, and chronic
pelvic pain,16e18 but also have many other medical illnesses.10
4. Risks for functional illnesses
As shown above, women with endometriosis often have
other functional and/or pathological illnesses, which might
worsen the established endometriosis-related diseases. A
recent study showed that women with endometriosis had a
higher risk of an attack of irritable bowel syndrome, with a
hazard ratio (HR) of 1.79 and 95% confidence interval (CI) of
1.55e2.07 ( p < 0.001).12 It is interesting that the new onset of
irritable bowel syndrome was especially higher within the 1st
year of follow-up (HR 1.90, 95% CI 1.42e2.55, p < 0.001) in
women with endometriosis.12 In addition, the increased risk of
irritable bowel syndrome could persist over 5 years.12 Wu and
colleagues12 tried to explain the association between endo-
metriosis and irritable bowel syndrome, and raised the hy-
pothesis that both diseases might share similar risk and
pathogenic factors, such as visceral hypersensitivity, similar
inflammatory processes in the peritoneal cavity and gastroin-
testinal mucosa, and mast cell activation.
Endometriosis might be also associated with other painful
diseases. For example, Dr Yang and colleagues1 found that
women with endometriosis were more likely to be diagnosed
with migraine headache during the follow-up (HR 1.70, 95%
CI 1.59e1.82, p < 0.001) than controls, and the diagnosis of
migraine headache was often made after the diagnosis of
endometriosis. Although the cause of comorbidity of endo-
metriosis and migraine headache is unknown, a number of
aspects of the pathophysiological pathways may explain the
apparent relationship, including the activation of sensory nerve
fibers within the endometriosis leading to central nervous
system hypersensitivity, and activation and degranulation of
mast cells within the endometriosis inducing the release of
proinflammatory and allergic mediators, which sensitize pri-
mary afferent meningeal nociceptive neurons and cause hy-
persensitivity and hyperalgesia.1
5. Increased risk of malignant tumors in women with
endometriosis
Women with endometriosis not only have the above-
mentioned benign diseases or health problems, but also might
be associated with much more severe health problems, for
example, development of malignancy. As early as 1925,
Sampson found a possible correlation between endometriosisand epithelial ovarian cancer (EOC), and soon after, many
epidemiologic studies, systematic reviews, and meta-analyses
indicated that women with endometriosis were at a risk of
the development of EOC.3 At least five domestic studies
focusing on the correlation between endometriosis and EOC
have been reported.3e5,19,20
The first study investigated the microenvironmental bio-
markers of different types of ovarian cancers arising from
endometriosis and found that these EOC displayed the
following characteristics and appeared frequently: 56% for
cyclooxygenase-2, 47% for AT-rich interactive domain 1A
mutation (expressed by the loss of the corresponding protein
BAF250a), 43% for estrogen receptor, 38% for hepatocyte
nuclear factor-1 beta, 37% for loss of phosphatase and tensin
homolog, and 13% for p53 mutation.19 Furthermore, studying
endometriosis-associated EOCs, such as clear cell carcinoma
and endometrioid cell carcinoma, Lai et al19 showed signifi-
cantly high positive rates of estrogen receptor in endometrioid
cell carcinoma (91%) and hepatocyte nuclear factor-1 beta in
clear cell carcinoma (65%). In addition, they found that the
staining results were similar between atypical endometriosis
glandular epithelium and contiguous malignant portions,
suggesting that endometriosis-associated EOCs may share
common molecular and genetic features between precursors
and cancers.19
The remaining four reports were epidemiologic stud-
ies.3e5,20 The first attempt to evaluate a possible correlation
between endometriosis and an increased risk of EOC in
Taiwan appeared in 2014.5 This study was performed using
data from the NHIRD of Taiwan and showed that the EOC
incidence rates of women with and without endometriosis
were 3.31 per 10,000 person-years and 0.99 per 10,000
person-years, respectively, contributing to an adjusted HR of
3.28 (95% CI 1.37e7.85, p < 0.01).5 This estimated three-fold
increase of the risk of EOC in women with endometriosis was
neither influenced by exposure time nor biased by surveil-
lance.5 Another study investigated the correlation between
endometriosis and EOC.4 Results showed that women with a
new surgically confirmed endometriosis had a higher risk of
EOC than those without.4 The EOC incidence rate of women
with endometriosis consistently increased with increasing age,
with 4.99 per 10,000 person-years in women aged <30 years
and 35.81 per 10,000 person-years in those aged more than
50 years, contributing to a risk of EOC constantly increasing
with age.4 The final study used data from the NHIRD to
explain why the risk of EOC in women with endometriosis
varied greatly; results showed that the risk of EOC in women
with endometriosis might be more apparent than that previ-
ously estimated by either systematic reviews or meta-analyses,
because data enrolled for analysis are often based on recalled
endometriosis, which resulted in only a two-fold increase.3
Besides the well-known correlation between endometriosis
and EOC, a correlation between endometriosis and other
malignancies, especially gynecologic cancers,11,20 has also
been evaluated in Taiwan. One study showed that women with
endometriosis had a significantly higher risk of endometrial
cancer than those without during a 10-year follow-up, with an
580 S.-W. Teng et al. / Journal of the Chinese Medical Association 79 (2016) 577e582adjusted HR of 2.83 (95% CI 1.49e5.35, p < 0.01).11 The
results of Yu et al's11 study also showed that age at diagnosis of
endometriosis might play an important role, since women with
endometriosis who were younger than 40 years did not have an
apparent increased risk of endometrial cancer compared with
those without endometriosis, but the risk for the development
of endometrial cancer was significantly increased in women
with endometriosis when they were older than 40 years, with
an adjusted HR of 7.08 (95% CI 2.33e21.55, p ¼ 0.007).
Another study by Kok and colleagues20 examined the
correlation between endometriosis and other malignancies,
including endometrial, breast, colorectal, and other cancers.
Overall, this study found that women with endometriosis and
adenomyosis had a higher risk of malignancy, with adjusted
HRs of 1.8 (95% CI 1.4e2.4, p < 0.05) and 1.8 (95% CI
1.3e2.7, p < 0.05), respectively.20 In terms of the localization
of endometriosis, women with ovarian endometriosis associ-
ated with/without endometriosis variants (endometriosis at
another site) had a higher risk of EOC and endometrial cancer,
with adjusted HRs of 4.56 (95% CI 1.72e12.11, p < 0.05) and
4.05 (95% CI 1.20e13.66, p < 0.05), respectively.20 By
contrast, women with main endometriosis within the uterus
accompanied with/without other areas of endometriosis also
had a higher risk of EOC and endometrial cancer, with
adjusted HRs of 5.50 (95% CI 1.95e15.50, p < 0.05) and 4.38
(95% CI 1.22e15.72, p < 0.05), respectively. With regard to
the risk of endometrial cancer, women with pure adenomyosis
without endometriosis in other sites had an unusually higher
risk of endometrial cancer (adjusted HR 5.13, 95% CI
1.36e19.40, p < 0.05).20 However, it is interesting to find that
women with uterine endometriosis (adenomyosis) mixing with
other sites of endometriosis had much higher risks of ovarian
and colorectal cancers, with adjusted HRs of 10.35 (95% CI
3.07e34.91, p < 0.05) and 13.04 (95% CI 2.21e77.04,
p < 0.05), respectively.20 Although colon and rectum are re-
ported as the second most common extragonadal sites for
malignant transformation of endometriosis,21 it is not clear
why women with adenomyosis mixing with other sites of
endometriosis are at a risk of colorectal cancer. It is relatively
confusing that estrogen promotes endometriosis growth,22 but
estrogen might be beneficial for protection from the develop-
ment of colorectal cancer, based on the findings from a pre-
vious scientific review23 and a recent prospective study.24 In
addition, if the theory of estrogen is acceptable for the path-
ogenesis of endometriosis, EOC, and endometrial cancer, it
can be further supposed that there is a possible correlation
between endometriosis and breast cancer. However, domestic
data did not show any correlation between endometriosis and
breast cancer,20 and from literature reviews, the available
published evidence is inconclusive.25
6. Study limitation
This review was mainly based on the results from domestic
data published between 2012 and 2015, and the data used for
these published articles were all obtained from the NHIRD.
The major issue with respect to the NHIRD is the accuracy ofthe diagnosis; therefore, without further validation, the results
should be read more carefully and the conclusion should avoid
a hasty generalization. Lee et al3 also confirmed this, since
they found that the incidence of endometriosis varied greatly.
In fact, to report the incidence of endometriosis, so far, nobody
could demonstrate the reality of the incidence.2 However, as
reported by Lee et al,3 women with endometriosis really had a
higher risk of ovarian cancer than those without, regardless of
which criteria were used, suggesting that the association be-
tween endometriosis and comorbidity is somewhat present. In
addition, numerous excellent articles are available in the
literature, including many in the top journals, such as Lancet
Oncology, Annals of Internal Medicine, JAMA Internal Med-
icine, Medicine, etc.,26e30 which report on studies based on
the data from the NHIRD, suggesting that information from
the NHIRD in Taiwan is valuable for clinical reference.
Although evidence from molecular or genetic studies might
partly explain the possibly similar pathogenesis or genetic
background between endometriosis and some of these
comorbidities, for example, ovarian cancers,31e33 we note that
the evidence is still not strong enough to establish a bridge
between the two.
In conclusion, evidence from nationwide large-scale pop-
ulation-based studies using domestic data suggests that women
with endometriosis might be at a higher risk of several chronic
diseases, including diabetes mellitus, cardiovascular disease,
chronic liver disease, and rheumatoid arthritis, as well as
fertility and pelvic inflammatory diseases, but possibly at a
lower risk of chronic renal disease,34 although we considered
the evidence for some comorbidities to be of low quality. In
addition to the abovementioned benign medical illnesses,
these women might have higher risks of many kinds of ma-
lignancies, such as ovarian cancer and uterine cancers. The
risk of comorbidity might be higher in women with endome-
triosis than was previously supposed, and these comorbidities
might be harmful to long-term health in such women. More
research is needed to determine whether women with endo-
metriosis are really at a risk of these comorbidities.
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